Kewaunee Scientific (NASDAQ:KEQU) CEO Thomas David Hull III Sells 2,177 Shares of Stock

Kewaunee Scientific Corporation (NASDAQ:KEQU) CEO Thomas David Hull III sold 2,177 shares of Kewaunee Scientific stock in a transaction that occurred on Wednesday, January 7th. The shares were sold at an average price of $37.50, for a total transaction of $81,637.50. Following the sale, the chief executive officer owned 33,000 shares in the company, valued at approximately $1,237,500. The trade was a 6.19% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Thomas David Hull III also recently made the following trade(s):

• On Wednesday, December 31st, Thomas David Hull III sold 629 shares of Kewaunee Scientific stock. The shares were sold at an average price of $37.66, for a total value of $23,688.14.
• On Tuesday, December 30th, Thomas David Hull III sold 29 shares of Kewaunee Scientific stock. The stock was sold at an average price of $38.00, for a total value of $1,102.00.
• On Monday, December 29th, Thomas David Hull III sold 884 shares of Kewaunee Scientific stock. The stock was sold at an average price of $38.01, for a total transaction of $33,600.84.
• On Monday, December 22nd, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The shares were sold at an average price of $39.00, for a total value of $39,000.00.

Kewaunee Scientific Stock Down 0.2%

Shares of KEQU opened at $37.16 on Friday. The firm has a fifty day moving average price of $39.00 and a 200-day moving average price of $46.88. The company has a current ratio of 2.48, a quick ratio of 1.71 and a debt-to-equity ratio of 0.81. The firm has a market capitalization of $106.65 million, a P/E ratio of 9.43 and a beta of 0.55. Kewaunee Scientific Corporation has a 12-month low of $30.33 and a 12-month high of $71.33.

Kewaunee Scientific (NASDAQ:KEQU) last announced its quarterly earnings results on Wednesday, December 10th. The technology company reported $0.91 earnings per share for the quarter. Kewaunee Scientific had a net margin of 4.11% and a return on equity of 22.39%. The firm had revenue of $70.10 million during the quarter. During the same period in the previous year, the company posted $1.01 EPS.

Analysts Set New Price Targets

A number of equities analysts have commented on KEQU shares. Weiss Ratings reissued a “hold (c+)” rating on shares of Kewaunee Scientific in a report on Wednesday, October 8th. Wall Street Zen lowered Kewaunee Scientific from a “buy” rating to a “hold” rating in a research report on Saturday, December 13th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Kewaunee Scientific currently has an average rating of “Hold”.

Hedge Funds Weigh In On Kewaunee Scientific

Institutional investors have recently bought and sold shares of the company. Goldman Sachs Group Inc. lifted its stake in shares of Kewaunee Scientific by 125.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 19,397 shares of the technology company’s stock valued at $764,000 after purchasing an additional 10,803 shares in the last quarter. Minerva Advisors LLC lifted its stake in shares of Kewaunee Scientific by 5.0% in the second quarter. Minerva Advisors LLC now owns 77,442 shares of the technology company’s stock worth $4,501,000 after acquiring an additional 3,677 shares in the last quarter. De Lisle Partners LLP boosted its stake in shares of Kewaunee Scientific by 6.7% during the 2nd quarter. De Lisle Partners LLP now owns 47,977 shares of the technology company’s stock valued at $2,811,000 after buying an additional 3,029 shares during the last quarter. Wedbush Securities Inc. acquired a new position in Kewaunee Scientific during the 2nd quarter worth $232,000. Finally, Morgan Dempsey Capital Management LLC lifted its holdings in Kewaunee Scientific by 41.8% during the 2nd quarter. Morgan Dempsey Capital Management LLC now owns 4,229 shares of the technology company’s stock worth $247,000 after buying an additional 1,247 shares during the last quarter. 32.69% of the stock is owned by institutional investors and hedge funds.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.

The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.